Capital Infra Trust IPO garnered bids for 2,32,77,600 equity shares against the total issue size of 8,83,83,750 shares, ...
Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...
After forming through the merger of three companies last summer, a Houston-based oil field services provider is going public.
Maze Therapeutics (MAZE), which is developing treatments for chronic kidney disease, has filed to raise $100M through an initial public offering. While the company didn't disclose terms in its SEC ...
The company estimates the IPO price will be between $4 and $5 per unit. For its nine months ended Sept. 30, Functional Brands had a loss of about $276,000 on revenue of $4.89 million. The company ...
Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...
Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, ...
The offering has a price range established between ₹275 and ₹290 per share, and it is scheduled to open for public ...
A biopharmaceutical company and its executives misled investors ahead of its 2024 initial public offering about a key ...
Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...
The initial public offering of dental products and solutions provider company Laxmi Dental Ltd., valued at Rs 698.06 crore, ...
Kingswood Capital Partners, LLC ("Kingswood") acted as the sole book-running manager for the Offering. Hunter Taubman Fischer ...